4dmedical Limited Stock Analysis

FDMDF Stock  USD 2.58  0.14  5.74%   
4DMedical Limited holds a debt-to-equity ratio of 0.018. 4DMedical's financial risk is the risk to 4DMedical stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

4DMedical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. 4DMedical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps 4DMedical Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect 4DMedical's stakeholders.
For many companies, including 4DMedical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for 4DMedical Limited, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, 4DMedical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that 4DMedical's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which 4DMedical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of 4DMedical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, 4DMedical is said to be less leveraged. If creditors hold a majority of 4DMedical's assets, the Company is said to be highly leveraged.
4DMedical Limited is overvalued with Real Value of 1.92 and Hype Value of 2.58. The main objective of 4DMedical pink sheet analysis is to determine its intrinsic value, which is an estimate of what 4DMedical Limited is worth, separate from its market price. There are two main types of 4DMedical's stock analysis: fundamental analysis and technical analysis.
The 4DMedical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and 4DMedical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 4DMedical Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median.

4DMedical Pink Sheet Analysis Notes

About 35.0% of the company shares are held by company insiders. The book value of 4DMedical was currently reported as 0.2. The company recorded a loss per share of 0.05. 4DMedical Limited had not issued any dividends in recent years. 4DMedical Limited operates as a medical technology company in Australia and the United States. The company was incorporated in 2012 and is based in Carlton, Australia. 4Dmedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 95 people.The quote for 4DMedical Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about 4DMedical Limited call the company at 61 3 9545 5940 or check out https://www.4dmedical.com.

4DMedical Limited Investment Alerts

4DMedical Limited is way too risky over 90 days horizon
4DMedical Limited appears to be risky and price may revert if volatility continues
The company reported the revenue of 1.05 M. Net Loss for the year was (24.59 M) with profit before overhead, payroll, taxes, and interest of 280.62 K.
4DMedical Limited has accumulated about 60.19 M in cash with (25.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2.
Roughly 35.0% of the company shares are held by company insiders

4DMedical Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 86.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate 4DMedical's market, we take the total number of its shares issued and multiply it by 4DMedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 3rd of February, 4DMedical shows the Coefficient Of Variation of 741.94, mean deviation of 4.69, and Risk Adjusted Performance of 0.1082. 4DMedical Limited technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm 4DMedical Limited maximum drawdown, and the relationship between the information ratio and downside variance to decide if 4DMedical Limited is priced fairly, providing market reflects its regular price of 2.58 per share. Please also double-check 4DMedical Limited total risk alpha, which is currently at 0.8554 to validate the company can sustain itself at some future date.

4DMedical Limited Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. 4DMedical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for 4DMedical Limited. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

4DMedical Predictive Daily Indicators

4DMedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of 4DMedical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

4DMedical Forecast Models

4DMedical's time-series forecasting models are one of many 4DMedical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary 4DMedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

4DMedical Limited Debt to Cash Allocation

Many companies such as 4DMedical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
4DMedical Limited has accumulated 1.3 M in total debt with debt to equity ratio (D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. 4DMedical Limited has a current ratio of 12.67, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist 4DMedical until it has trouble settling it off, either with new capital or with free cash flow. So, 4DMedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like 4DMedical Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for 4DMedical to invest in growth at high rates of return. When we think about 4DMedical's use of debt, we should always consider it together with cash and equity.

4DMedical Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the 4DMedical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of 4DMedical, which in turn will lower the firm's financial flexibility.

About 4DMedical Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how 4DMedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling 4DMedical shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as 4DMedical. By using and applying 4DMedical Pink Sheet analysis, traders can create a robust methodology for identifying 4DMedical entry and exit points for their positions.
4DMedical Limited operates as a medical technology company in Australia and the United States. The company was incorporated in 2012 and is based in Carlton, Australia. 4Dmedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 95 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding 4DMedical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

Complementary Tools for 4DMedical Pink Sheet analysis

When running 4DMedical's price analysis, check to measure 4DMedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4DMedical is operating at the current time. Most of 4DMedical's value examination focuses on studying past and present price action to predict the probability of 4DMedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4DMedical's price. Additionally, you may evaluate how the addition of 4DMedical to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios